WallStreetZenWallStreetZen

NYSEMKT: INFU
Infusystem Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Infusystem Holdings earnings were $5.5M for the trailing 12 months ending Sep 30, 2025, with 333.3% growth year over year. The latest INFU earnings report on Sep 30, 2025 announced Q3 2025 earnings of $2.3M, down 13.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INFU reported annual earnings of $2.3M, with 168.9% growth.

INFU past earnings growth

How has INFU's earnings growth performed historically?

Company
333.33%
Industry
10.35%
Market
54.8%
INFU's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INFU's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INFU's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INFU earnings history

Current Revenue
$141.1M
Current Earnings
$5.5M
Current Profit Margin
3.9%
INFU's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

INFU Return on Equity

Current Company
9.9%
Current Industry
9.6%
Current Market
35.2%
INFU's Return on Equity (9.9%)... subscribe to Premium to read more.
High Return on Equity Performance

INFU undefined

Current Company
5.4%
Current Industry
8.3%
INFU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INFU announces earnings.

INFU undefined

Current Company
13.46%
Current Industry
11.1%
INFU has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INFU vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INFU$24.16M$5.52M-7.31%$0.26
UTMD$17.60M$11.62M+2.10%$3.54
OSUR-$47.61M-$60.24MN/A-$0.80
NYXH-$81.43M-$97.35MN/A-$2.61
AVR-$82.60M-$84.32MN/A-$2.52
View Top Medical Stocks

Infusystem Holdings Earnings Reports & History FAQ

What were Infusystem Holdings's earnings last quarter?

On INFU's earnings call on Invalid Date, Infusystem Holdings (NYSEMKT: INFU) reported Q3 2025 earnings per share (EPS) of $0.11, up 37.5% year over year. Total INFU earnings for the quarter were $2.26 million. In the same quarter last year, Infusystem Holdings's earnings per share (EPS) was $0.08.

If you're new to stock investing, here's how to buy Infusystem Holdings stock.

Is Infusystem Holdings profitable or losing money?

As of the last Infusystem Holdings earnings report, Infusystem Holdings is currently profitable. Infusystem Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $5.52 million, a 272.24% increase year over year.

What was INFU's earnings growth in the past year?

As of Infusystem Holdings's earnings date in Invalid Date, Infusystem Holdings's earnings has grown 333.33% year over year. This is 322.98 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 10.35%. INFU earnings in the past year totalled $5.52 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.